These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38477506)

  • 1. Significance of the cribriform morphology area ratio for biochemical recurrence in Gleason score 4 + 4 prostate cancer patients following robot-assisted radical prostatectomy.
    Shimodaira K; Inoue R; Hashimoto T; Satake N; Shishido T; Namiki K; Harada K; Nagao T; Ohno Y
    Cancer Med; 2024 Mar; 13(5):e7086. PubMed ID: 38477506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
    Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP
    Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.
    Leo P; Chandramouli S; Farré X; Elliott R; Janowczyk A; Bera K; Fu P; Janaki N; El-Fahmawi A; Shahait M; Kim J; Lee D; Yamoah K; Rebbeck TR; Khani F; Robinson BD; Shih NNC; Feldman M; Gupta S; McKenney J; Lal P; Madabhushi A
    Eur Urol Focus; 2021 Jul; 7(4):722-732. PubMed ID: 33941504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
    Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
    Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Factors for Early Biochemical Recurrence Following Robot-assisted Radical Prostatectomy.
    Mitsunari K; Fukushima H; Kurata H; Harada J; Nakamura Y; Matsuo T; Ohba K; Mochizuki Y; Imamura R
    Anticancer Res; 2024 Jul; 44(7):3149-3154. PubMed ID: 38925837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.
    Kweldam CF; Kümmerlin IP; Nieboer D; Verhoef EI; Steyerberg EW; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ; van Leenders GJ
    Eur J Cancer; 2016 Oct; 66():26-33. PubMed ID: 27522247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the presence of tertiary Gleason grade 5 in robot-assisted radical prostatectomy specimens in Japanese patients with clinically localized prostate cancer.
    Kamoda N; Ohori M; Hirasawa Y; Inoue R; Hashimoto T; Satake N; Gondo T; Nakagami Y; Nagao T; Ohno Y
    Jpn J Clin Oncol; 2019 Mar; 49(3):276-280. PubMed ID: 30649377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer.
    Morizane S; Honda M; Shimizu R; Teraoka S; Nishikawa R; Tsounapi P; Kimura Y; Iwamoto H; Hikita K; Takenaka A
    Int J Clin Oncol; 2020 Jul; 25(7):1398-1404. PubMed ID: 32333202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prognostic factors for biochemical recurrence after robot-assisted radical prostatectomy in Japan.
    Hashimoto T; Yoshioka K; Gondo T; Ozu C; Horiguchi Y; Namiki K; Ohno Y; Ohori M; Nakashima J; Tachibana M
    Int J Clin Oncol; 2014 Aug; 19(4):702-7. PubMed ID: 24048883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.
    Tanimoto R; Fashola Y; Scotland KB; Calvaresi AE; Gomella LG; Trabulsi EJ; Lallas CD
    BMC Urol; 2015 Apr; 15():27. PubMed ID: 25879548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cribriform Morphology in Gleason Score 3+4 Moderate-Risk Prostate Cancer: Is it Risk Factor for Biochemical Recurrence?
    Yahşi S; Ceylan C; Kizilkan Y; Şenel S; Ceviz K
    Arch Esp Urol; 2022 May; 75(4):325-329. PubMed ID: 35818912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer.
    Greenland NY; Cooperberg MR; Wong AC; Chan E; Carroll PR; Simko JP; Stohr BA
    Investig Clin Urol; 2022 Jan; 63(1):27-33. PubMed ID: 34983120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy.
    Ha YS; Kang DI; Kim JH; Joung JY; Yu J; Parihar JS; Salmasi AH; Horie S; Kim WJ; Yi Kim I
    Can J Urol; 2014 Jun; 21(3):7290-7. PubMed ID: 24978359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram.
    Abdollah F; Klett DE; Sood A; Sammon JD; Pucheril D; Dalela D; Diaz M; Peabody JO; Trinh QD; Menon M
    BJU Int; 2015 Nov; 116(5):703-12. PubMed ID: 25413443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.
    Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Helleman J; Roobol MJ; van Leenders GJLH
    Mod Pathol; 2019 Jan; 32(1):139-146. PubMed ID: 30349027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical outcomes after robot-assisted radical prostatectomy in patients with follow-up more than 5-years.
    Kim KH; Lim SK; Shin TY; Chung BH; Hong SJ; Rha KH
    Asian J Androl; 2013 May; 15(3):404-8. PubMed ID: 23524532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.